| Douglas George Nilson, MD | |
|
1 Medical Center Dr, Emergency Department, Biddeford, ME 04005-9422 | |
| (207) 294-5000 | |
| Not Available |
| Full Name | Douglas George Nilson |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Experience | 19 Years |
| Location | 1 Medical Center Dr, Biddeford, Maine |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1609091503 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 018117 (Maine) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Springfield Hospital | Springfield, VT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Bluewater Emergency Partners Of Brunswick, Llc | 3375774227 | 10 |
News Archive
Scientists have discovered a possible link between Parkinson's disease and a gene impacted by a neurotoxin found in blue-green algae.
Adocia, a biotechnology company specialized in the development of ‘best-in-class' medicines from already approved therapeutic proteins, in particular proteins and oncologic treatments, launches today a phase IIa clinical trial on its ultra-fast acting formulation of insulin Lispro (Humalog, Eli Lilly) using its proprietary technology BioChaperone).
Findings from a new retrospective cohort study presented at the American College of Gastroenterology's 74th Annual Scientific meeting in San Diego indicate that patients with Inflammatory Bowel Disease (IBD), especially those receiving the thiopurine class of medications to treat IBD, may be at risk for developing non-melanoma skin cancer (NMSC).
Imagine a single drug that would treat most, if not all, autoimmune disorders, such as asthma, inflammatory bowel disease, and Lupus. That might not be so hard to do thanks to a team of researchers who have discovered a molecule normally used by the body to prevent unnecessary immune reactions.
› Verified 7 days ago
| Entity Name | Mercy Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1629078712 PECOS PAC ID: 6103737812 Enrollment ID: O20040217000943 |
News Archive
Scientists have discovered a possible link between Parkinson's disease and a gene impacted by a neurotoxin found in blue-green algae.
Adocia, a biotechnology company specialized in the development of ‘best-in-class' medicines from already approved therapeutic proteins, in particular proteins and oncologic treatments, launches today a phase IIa clinical trial on its ultra-fast acting formulation of insulin Lispro (Humalog, Eli Lilly) using its proprietary technology BioChaperone).
Findings from a new retrospective cohort study presented at the American College of Gastroenterology's 74th Annual Scientific meeting in San Diego indicate that patients with Inflammatory Bowel Disease (IBD), especially those receiving the thiopurine class of medications to treat IBD, may be at risk for developing non-melanoma skin cancer (NMSC).
Imagine a single drug that would treat most, if not all, autoimmune disorders, such as asthma, inflammatory bowel disease, and Lupus. That might not be so hard to do thanks to a team of researchers who have discovered a molecule normally used by the body to prevent unnecessary immune reactions.
› Verified 7 days ago
| Entity Name | Mainehealth |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1790265502 PECOS PAC ID: 7517860588 Enrollment ID: O20040701000166 |
News Archive
Scientists have discovered a possible link between Parkinson's disease and a gene impacted by a neurotoxin found in blue-green algae.
Adocia, a biotechnology company specialized in the development of ‘best-in-class' medicines from already approved therapeutic proteins, in particular proteins and oncologic treatments, launches today a phase IIa clinical trial on its ultra-fast acting formulation of insulin Lispro (Humalog, Eli Lilly) using its proprietary technology BioChaperone).
Findings from a new retrospective cohort study presented at the American College of Gastroenterology's 74th Annual Scientific meeting in San Diego indicate that patients with Inflammatory Bowel Disease (IBD), especially those receiving the thiopurine class of medications to treat IBD, may be at risk for developing non-melanoma skin cancer (NMSC).
Imagine a single drug that would treat most, if not all, autoimmune disorders, such as asthma, inflammatory bowel disease, and Lupus. That might not be so hard to do thanks to a team of researchers who have discovered a molecule normally used by the body to prevent unnecessary immune reactions.
› Verified 7 days ago
| Entity Name | Southern Maine Health Care |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1659392819 PECOS PAC ID: 0143208348 Enrollment ID: O20040713001060 |
News Archive
Scientists have discovered a possible link between Parkinson's disease and a gene impacted by a neurotoxin found in blue-green algae.
Adocia, a biotechnology company specialized in the development of ‘best-in-class' medicines from already approved therapeutic proteins, in particular proteins and oncologic treatments, launches today a phase IIa clinical trial on its ultra-fast acting formulation of insulin Lispro (Humalog, Eli Lilly) using its proprietary technology BioChaperone).
Findings from a new retrospective cohort study presented at the American College of Gastroenterology's 74th Annual Scientific meeting in San Diego indicate that patients with Inflammatory Bowel Disease (IBD), especially those receiving the thiopurine class of medications to treat IBD, may be at risk for developing non-melanoma skin cancer (NMSC).
Imagine a single drug that would treat most, if not all, autoimmune disorders, such as asthma, inflammatory bowel disease, and Lupus. That might not be so hard to do thanks to a team of researchers who have discovered a molecule normally used by the body to prevent unnecessary immune reactions.
› Verified 7 days ago
| Entity Name | Down East Community Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1689670242 PECOS PAC ID: 6709858194 Enrollment ID: O20040809000314 |
News Archive
Scientists have discovered a possible link between Parkinson's disease and a gene impacted by a neurotoxin found in blue-green algae.
Adocia, a biotechnology company specialized in the development of ‘best-in-class' medicines from already approved therapeutic proteins, in particular proteins and oncologic treatments, launches today a phase IIa clinical trial on its ultra-fast acting formulation of insulin Lispro (Humalog, Eli Lilly) using its proprietary technology BioChaperone).
Findings from a new retrospective cohort study presented at the American College of Gastroenterology's 74th Annual Scientific meeting in San Diego indicate that patients with Inflammatory Bowel Disease (IBD), especially those receiving the thiopurine class of medications to treat IBD, may be at risk for developing non-melanoma skin cancer (NMSC).
Imagine a single drug that would treat most, if not all, autoimmune disorders, such as asthma, inflammatory bowel disease, and Lupus. That might not be so hard to do thanks to a team of researchers who have discovered a molecule normally used by the body to prevent unnecessary immune reactions.
› Verified 7 days ago
| Entity Name | Bluewater Emergency Partners Of Brunswick, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1043640204 PECOS PAC ID: 3375774227 Enrollment ID: O20140319000012 |
News Archive
Scientists have discovered a possible link between Parkinson's disease and a gene impacted by a neurotoxin found in blue-green algae.
Adocia, a biotechnology company specialized in the development of ‘best-in-class' medicines from already approved therapeutic proteins, in particular proteins and oncologic treatments, launches today a phase IIa clinical trial on its ultra-fast acting formulation of insulin Lispro (Humalog, Eli Lilly) using its proprietary technology BioChaperone).
Findings from a new retrospective cohort study presented at the American College of Gastroenterology's 74th Annual Scientific meeting in San Diego indicate that patients with Inflammatory Bowel Disease (IBD), especially those receiving the thiopurine class of medications to treat IBD, may be at risk for developing non-melanoma skin cancer (NMSC).
Imagine a single drug that would treat most, if not all, autoimmune disorders, such as asthma, inflammatory bowel disease, and Lupus. That might not be so hard to do thanks to a team of researchers who have discovered a molecule normally used by the body to prevent unnecessary immune reactions.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Douglas George Nilson, MD 1 Medical Center Dr, Southern Maine Medical Center Emergency Department, Biddeford, ME 04005-9422 Ph: (207) 294-5000 | Douglas George Nilson, MD 1 Medical Center Dr, Emergency Department, Biddeford, ME 04005-9422 Ph: (207) 294-5000 |
News Archive
Scientists have discovered a possible link between Parkinson's disease and a gene impacted by a neurotoxin found in blue-green algae.
Adocia, a biotechnology company specialized in the development of ‘best-in-class' medicines from already approved therapeutic proteins, in particular proteins and oncologic treatments, launches today a phase IIa clinical trial on its ultra-fast acting formulation of insulin Lispro (Humalog, Eli Lilly) using its proprietary technology BioChaperone).
Findings from a new retrospective cohort study presented at the American College of Gastroenterology's 74th Annual Scientific meeting in San Diego indicate that patients with Inflammatory Bowel Disease (IBD), especially those receiving the thiopurine class of medications to treat IBD, may be at risk for developing non-melanoma skin cancer (NMSC).
Imagine a single drug that would treat most, if not all, autoimmune disorders, such as asthma, inflammatory bowel disease, and Lupus. That might not be so hard to do thanks to a team of researchers who have discovered a molecule normally used by the body to prevent unnecessary immune reactions.
› Verified 7 days ago
Margaret Shannon Griffin, PA-C Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 24 West Cole Rd Ste 104, Biddeford, ME 04005 Phone: 207-283-1602 | |
Mr. Zachary Bernard Tillett, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1 Medical Center Dr, Biddeford, ME 04005 Phone: 207-283-7000 | |
Gina Marie Quinn-skillings, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1 Medical Center Dr, Biddeford, ME 04005 Phone: 207-283-7100 Fax: 207-283-7850 | |
Dr. Keith Rosenberg, M.D., M.P.H. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1 Medical Center Dr, Biddeford, ME 04005 Phone: 207-283-7000 | |
Madeleine Marie Puissant, MD, PHD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1 Medical Center Dr, Biddeford, ME 04005 Phone: 207-662-0111 | |
Christopher P Cox, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1 Medical Center Dr, Biddeford, ME 04005 Phone: 207-283-7100 Fax: 207-283-7850 | |
Dr. Jessica H Stevens, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: One Medical Center Drive, Biddeford, ME 04005 Phone: 207-294-5000 Fax: 207-282-9180 |